Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol

BMC Medical Genetics

Volumn 9, Issue , 2008, Pages

  Kolz, Melanie ^a   Baumert, Jens ^a   Müller, Martina ^a,b   Khuseyinova, Natalie ^c   Klopp, Norman ^a   Thorand, Barbara ^a   Meisinger, Christine ^a,d   Herder, Christian ^e   Koenig, Wolfgang ^c   Illig, Thomas ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d KLINIKUM AUGSBURG   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INCIDENCE; INNATE IMMUNITY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 4; VARIATION (GENETICS);

EID: 42049098225     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-9-9     Document Type: Article

References (36)

1. Kolb H Mandrup-Poulsen T An immune origin of type 2 diabetes? Diabetologia 2005, 48:1038-1050. 10.1007/s00125-005-1764-9 15864529
2. Duncan BB Schmidt MI The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes Diabetes Technol Ther 2006, 8:7-17. 10.1089/dia.2006.8.7 16472046
3. Pickup JC Crook MA Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998, 41:1241-1248. 10.1007/s001250051058 9794114
4. Medzhitov R Preston-Hurlburt P Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 1997, 388:394-397. 10.1038/41131 9237759
5. Barton GM Medzhitov R Toll-like receptor signaling pathways Science 2003, 300:1524-1525. 10.1126/science.1085536 12791976
6. Poltorak A He X Smirnova I Liu MY Van Huffel C Du X Birdwell D Alejos E Silva M Galanos C Freudenberg M Ricciardi-Castagnoli P Layton B Beutler B Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene Science 1998, 282:2085-2088. 10.1126/science.282.5396.2085 9851930
7. Ohashi K Burkart V Flohe S Kolb H Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex J Immunol 2000, 164:558-561. 10623794
8. Smiley ST King JA Hancock WW Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4 J Immunol 2001, 167:2887-2894. 11509636
9. Miller YI Viriyakosol S Binder CJ Feramisco JR Kirkland TN Witztum JL Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells J Biol Chem 2003, 278:1561-1568. 10.1074/jbc.M209634200 12424240
10. Xu XH Shah PK Faure E Equils O Thomas L Fishbein MC Luthringer D Xu XP Rajavashisth TB Yano J Kaul S Arditi M Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL Circulation 2001, 104:3103-3108. 10.1161/ hc5001.100631 11748108
11. Shi H Kokoeva MV Inouye K Tzameli I Yin H Flier JS TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 2006, 116:3015-3025. 1616196 17053832 10.1172/JCI28898
12. Carr ME Diabetes mellitus: A hypercoagulable state J Diabetes Complications 2001, 15:44-54. 10.1016/S1056-8727(00)00132-X 11259926
13. Keren P George J Shaish A Levkovitz H Janakovic Z Afek A Goldberg I Kopolovic J Keren G Harats D Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: Establishment of a combined model and association with heat shock protein 65 immunity Diabetes 2000, 49:1064-1069. 10.2337/diabetes.49.6.1064 10866061
14. Streja D Cressey P Rabkin SW Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus J Diabetes Complications 2003, 17:120-127. 10.1016/ S1056-8727(02)00204-0 12738395
15. Guha M Mackman N LPS induction of gene expression in human monocytes Cell Signal 2001, 13:85-94. 10.1016/S0898-6568(00)00149-2 11257452
16. Barnes PJ Karin M Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases N Engl J Med 1997, 336:1066-1071. 10.1056/NEJM199704103361506 9091804
17. Arbour NC Lorenz E Schutte BC Zabner J Kline JN Jones M Frees K Watt JL Schwartz DA TLR4 mutations are associated with endotoxin hyporesponsiveness in humans Nat Genet 2000, 25:187-191. 10.1038/76048 10835634
18. Kiechl S Lorenz E Reindl M Wiedermann CJ Oberhollenzer F Bonora E Willeit J Schwartz DA Toll-like receptor 4 polymorphisms and atherogenesis N Engl J Med 2002, 347:185-192. 10.1056/NEJMoa012673 12124407
19. Thorand B Kolb H Baumert J Koenig W Chambless L Meisinger C Illig T Martin S Herder C Elevated levels of interleukin-18 predict the development of type 2 diabetes: Results from the MONICA/KORA Augsburg Study, 1984-2002 Diabetes 2005, 54:2932-2938. 10.2337/ diabetes.54.10.2932 16186395
20. Holle R Happich M Lowel H Wichmann HE KORA - a research platform for population based health research Gesundheitswesen 2005, 67 Suppl 1:S19-S25. 16032513
21. National Center for Biotechnology Information SNP database dbSNP http://www.ncbi.nlm.nih.gov/SNP/
22. Weidinger S Klopp N Wagenpfeil S Rummler L Schedel M Kabesch M Schafer T Darsow U Jakob T Behrendt H Wichmann HE Ring J Illig T Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults J Med Genet 2004, 41:658-663. 10.1136/ jmg.2004.020263 15342695
23. Meisinger C Thorand B Schneider A Stieber J Doring A Lowel H Sex differences in risk factors for incident type 2 diabetes mellitus: The MONICA Augsburg cohort study Arch Intern Med 2002, 162:82-89. 10.1001/ archinte.162.1.82 11784224
24. Barlow WE Robust variance estimation for the case-cohort design Biometrics 1994, 50:1064-1072. 10.2307/2533444 7786988
25. Thorand B Baumert J Kolb H Meisinger C Chambless L Koenig W Herder C Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 Diabetes Care 2007, 30:854-860. 10.2337/dc06-1693 17392546
26. Schaid DJ Rowland CM Tines DE Jacobson RM Poland GA Score tests for association between traits and haplotypes when linkage phase is ambiguous Am J Hum Genet 2002, 70:425-434. 384917 11791212 10.1086/338688
27. Li J Ji L Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix Heredity 2005, 95:221-227. 10.1038/ sj.hdy.6800717 16077740
28. R Project for Statistical Computing http://www.R-project.org
29. Illig T Bongardt F Schopfer A Holle R Muller S Rathmann W Koenig W Meisinger C Wichmann HE Kolb H The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome Diabetes 2003, 52:2861-2864. 10.2337/diabetes.52.11.2861 14578307
30. Kolek MJ Carlquist JF Muhlestein JB Whiting BM Horne BD Bair TL Anderson JL Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes Am Heart J 2004, 148:1034-1040. 10.1016/ j.ahj.2004.05.049 15632890
31. Rudofsky G Jr. Reismann P Witte S Humpert PM Isermann B Chavakis T Tafel J Nosikov VV Hamann A Nawroth P Bierhaus A Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes Diabetes Care 2004, 27:179-183. 10.2337/diacare.27.1.179 14693986
32. Mohammad MK Morran M Slotterbeck B Leaman DW Sun Y Grafenstein H Hong SC McInerney MF Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse Int Immunol 2006, 18:1101-1113. 10.1093/intimm/ dxl045 16728431
33. Song MJ Kim KH Yoon JM Kim JB Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes Biochem Biophys Res Commun 2006, 346:739-745. 10.1016/j.bbrc.2006.05.170 16781673
34. Boekholdt SM Agema WR Peters RJ Zwinderman AH van der Wall EE Reitsma PH Kastelein JJ Jukema JW Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events Circulation 2003, 107:2416-2421. 10.1161/01.CIR.0000068311.40161.28 12742999
35. Castrillo A Joseph SB Vaidya SA Haberland M Fogelman AM Cheng G Tontonoz P Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism Mol Cell 2003, 12:805-816. 10.1016/S1097-2765(03)00384-8 14580333
36. Bjorkbacka H Kunjathoor VV Moore KJ Koehn S Ordija CM Lee MA Means T Halmen K Luster AD Golenbock DT Freeman MW Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways Nat Med 2004, 10:416-421. 10.1038/ nm1008 15034566